Filing metadata

Accession number
0001209191-21-007784
Form type
Form 3
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Feb 04, 2021
Reporting period
Feb 02, 2021
Description
Initial ownership

Explore SEC Filings Hub